(Q34275005)

reason for preferred rank

1 August 2017

title

A Clinical Trial of 7α-Methyl-19-Nortestosterone Implants for Possible Use as a Long-Acting Contraceptive for Men (English)

1 reference

https://api.crossref.org/works/10.1210/JC.2002-022043

29 March 2024

A clinical trial of 7 alpha-methyl-19-nortestosterone implants for possible use as a long-acting contraceptive for men (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14602755

29 March 2024

1 reference

https://api.crossref.org/works/10.1210/JC.2002-022043

29 March 2024

1 reference

https://api.crossref.org/works/10.1210/JC.2002-022043

29 March 2024

4

Eberhard Nieschlag

1 reference

1 August 2017

author name string

Sigrid von Eckardstein

1

1 reference

1 August 2017

Gabriela Noe

2

1 reference

1 August 2017

Vivian Brache

3

1 reference

1 August 2017

Horacio Croxatto

5

1 reference

1 August 2017

Francisco Alvarez

6

1 reference

1 August 2017

Alfred Moo-Young

7

1 reference

1 August 2017

Irving Sivin

8

1 reference

1 August 2017

Narender Kumar

9

1 reference

1 August 2017

Margaret Small

10

1 reference

1 August 2017

Kalyan Sundaram

11

1 reference

1 August 2017

International Committee for Contraception Research, The Population Council

12

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

full work available at URL

1 August 2017

published in

The Journal of Clinical Endocrinology and Metabolism

1 reference

1 August 2017

volume

88

1 reference

1 August 2017

issue

11

1 reference

1 August 2017

page(s)

5232-5239

1 reference

Pregnancies associated with sperm concentrations below 10 million/ml in clinical studies of a potential male contraceptive method, monthly depot medroxyprogesterone acetate and testosterone esters

1 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1210/JC.2002-022043

Contraceptive efficacy of testosterone-induced azoospermia in normal men

29 March 2024

2

1 reference

https://api.crossref.org/works/10.1210/JC.2002-022043

Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men.

29 March 2024

3

1 reference

https://api.crossref.org/works/10.1210/JC.2002-022043

A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive.

29 March 2024

7

1 reference

https://api.crossref.org/works/10.1210/JC.2002-022043

Low dose of cyproterone acetate and testosterone enanthate for contraception in men.

29 March 2024

8

1 reference

https://api.crossref.org/works/10.1210/JC.2002-022043

Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism

29 March 2024

9

1 reference

https://api.crossref.org/works/10.1210/JC.2002-022043

Intramuscular testosterone undecanoate with or without oral levonorgestrel: a randomized placebo-controlled feasibility study for male contraception

29 March 2024

10

1 reference

https://api.crossref.org/works/10.1210/JC.2002-022043

Desogestrel plus testosterone effectively suppresses spermatogenesis but also causes modest weight gain and high-density lipoprotein suppression.

29 March 2024

13

1 reference

https://api.crossref.org/works/10.1210/JC.2002-022043

The biological activity of 7 alpha-methyl-19-nortestosterone is not amplified in male reproductive tract as is that of testosterone

29 March 2024

15

1 reference

https://api.crossref.org/works/10.1210/JC.2002-022043

Pharmacokinetics and pharmacodynamics of 7alpha-methyl-19-nortestosterone after intramuscular administration in healthy men

29 March 2024

16

1 reference

https://api.crossref.org/works/10.1210/JC.2002-022043

Gonadotrophin and testosterone suppression by 7alpha-methyl-19-nortestosterone acetate administered by subdermal implant to healthy men

29 March 2024

17

1 reference

https://api.crossref.org/works/10.1210/JC.2002-022043

Radioimmunoassay of 7 alpha-methyl-19-nortestosterone and investigation of its pharmacokinetics in animals

29 March 2024

23

1 reference

https://api.crossref.org/works/10.1210/JC.2002-022043

Combination of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) and depot-medroxyprogesterone-acetate (Clinovir) for male contraception

29 March 2024

27

1 reference

https://api.crossref.org/works/10.1210/JC.2002-022043

Efficacy and acceptability of testosterone implants, alone or in combination with a 5alpha-reductase inhibitor, for male hormonal contraception

29 March 2024

30

1 reference

https://api.crossref.org/works/10.1210/JC.2002-022043

Aromatization of 7α-Methyl-19-nortestosterone by human placental microsomes in vitro

29 March 2024

31

1 reference

https://api.crossref.org/works/10.1210/JC.2002-022043

A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men.

29 March 2024

32

1 reference

https://api.crossref.org/works/10.1210/JC.2002-022043

A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency

29 March 2024

33

1 reference

https://api.crossref.org/works/10.1210/JC.2002-022043

Testosterone replacement therapy in older adult men.

29 March 2024

34

1 reference

https://api.crossref.org/works/10.1210/JC.2002-022043

Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial.

29 March 2024

35

1 reference

https://api.crossref.org/works/10.1210/JC.2002-022043

Effect of testosterone treatment on bone mineral density in men over 65 years of age.

29 March 2024

36

1 reference

https://api.crossref.org/works/10.1210/JC.2002-022043

Effect of transdermal testosterone treatment on serum lipid and apolipoprotein levels in men more than 65 years of age.

29 March 2024

37

1 reference

https://api.crossref.org/works/10.1210/JC.2002-022043

Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men.

29 March 2024

38

1 reference

https://api.crossref.org/works/10.1210/JC.2002-022043

Androgens and coronary artery disease

29 March 2024

39

1 reference

https://api.crossref.org/works/10.1210/JC.2002-022043

29 March 2024

Identifiers

1 reference

1 August 2017

1 reference